Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: MacroRisk Analytics/EconomicInvestor
Provider: ValuEngine, Inc.
Provider: S&P Capital IQ Quantitative Report

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Harvard Bioscience Inc reiterates FY 2014 guidance

Thursday, 1 May 2014 07:04am EDT 

Harvard Bioscience Inc:Reiterates FY 2014 guidance from Feb. 27, which included revenues to be about same as FY 2013 revenues, which were $105.2 mln.Expects to report FY 2014 non-GAAP income from continuing operations of $0.26 per diluted share.Expects FY 2014 GAAP income from continuing operations of $0.14 per diluted share. 

Company Quote

26 Feb 2015